(Q39879612)

15 September 2017

Lack of pharmacokinetic interaction between cefepime and amikacin in humans (English)

1 reference

15 September 2017

1 reference

1 reference

R. H. Barbhaiya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510431

3 October 2022

C. A. Knupp

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510431

3 October 2022

M. Pfeffer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510431

3 October 2022

K. A. Pittman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510431

3 October 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

PMC publication ID

191590

full work available at URL

15 September 2017

https://europepmc.org/articles/PMC191590

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510431

https://europepmc.org/articles/PMC191590?pdf=render

3 October 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1510431

Antimicrobial Agents and Chemotherapy

3 October 2022

published in

1 reference

15 September 2017

36

1 reference

15 September 2017

7

1 reference

15 September 2017

1382-1386

1 reference

Estimation of mean residence time from data obtained when multiple-dosing steady state has been reached

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Clinical Pharmacokinetics of Aminoglycoside Antibiotics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Inactivation of gentamicin by penicillins in patients with renal failure

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Pharmacokinetics of cefepime in subjects with renal insufficiency

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Gentamicin and Ticarcillin Serum Levels

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=191590

Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin

20 August 2018

1 reference

12 December 2020

Disposition of the cephalosporin cefepime in normal and renally impaired subjects

1 reference

12 December 2020

High-performance liquid chromatographic assays for the quantification of amikacin in human plasma and urine

1 reference

12 December 2020

Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects

1 reference

12 December 2020

Laboratory and Clinical Conditions for Gentamicin Inactivation by Carbenicillin

1 reference

12 December 2020

Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.36.7.1382

1 reference

15 September 2017

1 reference

PMC publication ID

191590

15 September 2017

1 reference

PMC publication ID

191590